🏛️ Verified NIH Record • Updated 2025-07-03
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters (NCT05029063)
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters: a Randomized Controlled Trial
🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Ottawa Hospital Research Institute
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the full trial is to determine the efficacy and safety of prophylactic dose rivaroxaban to prevent VTE among cancer patients with CVC.
Who can join: Review the eligibility criteria below.
Location: Nova Scotia Health — Halifax, Nova Scotia
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Nova Scotia Health — Halifax, Nova Scotia
- William Osler Health System — Brampton, Ontario
- HHS - Juravinski Hospital — Hamilton, Ontario
- Ottawa Hospital Research Institute- The Ottawa Hospital — Ottawa, Ontario
- Sault Area Hospital — Sault Ste. Marie, Ontario
- Niagara Health — St. Catharines, Ontario
- Windsor Regional Hospital — Windsor, Ontario
- CISSS Montérégie-Centre HOPITAL CHARLES LEMOYNE — Greenfield Park, Quebec
- Centre Intégré de santé et de services sociaux de Chaudière-Appalaches — Lévis, Quebec
- Jewish General Hospital — Montreal, Quebec
- McGill University Health Center — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (613) 737-8899
Email: byazji@ohri.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Thromboembolism
- Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery — Charleston, South Carolina
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism — Basking Ridge, New Jersey
- Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty — Miami, Florida
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Scottsdale, Arizona
- Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis — Ottawa, Ontario
Explore by condition: All Venous Thromboembolism clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.